A practical regiospecific synthesis of 9-nitrocamptothecin

被引：3
|
作者：
Fu, QingQuan
Chen, Zhiyong
机构：
[1] Chinese Acad Sci, Chengdu Inst Organ Chem, Key Lab Asymmet Synth & Chirotechnol Sichuan Prov, Chengdu 610041, Peoples R China
[2] Chinese Acad Sci, Chengdu Inst Organ Chem, Union Lab Asymmetr Synth, Chengdu 610041, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Beijing 10049, Peoples R China
来源：
SYNTHESIS-STUTTGART | 2006年 / 12期
关键词：
9-nitrocamptothecin; nitration; reduction of sulfonate;
D O I：
10.1055/s-2006-942359
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
9-Nitrocamptothecin has shown potent antitumor activity against many types of human cancers. A practical scale-up procedure for this compound is reported by selective reduction of corresponding sulfonate.
引用
收藏
页码：1940 / 1942
页数：3
相关论文
共 50 条
  • [21] A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors
    Zhao Yan
    Zhongling Zhu
    Kai Li
    Peng Chen
    Liuchun Wang
    Chun Huang
    Jinhuai Xue
    Meijun Liu
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 955 - 961
  • [22] Development of a bioanalytical liquid chromatography method for quantitation of 9-nitrocamptothecin in human plasma
    Gounder, MK
    Sun, SL
    Sands, H
    Lin, Y
    Shih, WCJ
    Gu, ZM
    Charles-Williams, S
    Roychowdhury, M
    Rajendra, R
    Rubin, EH
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 799 (01): : 63 - 72
  • [23] Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes
    William C. Zamboni
    Ramesh K. Ramanathan
    Howard L. McLeod
    Sridhar Mani
    Douglas M. Potter
    Sandra Strychor
    Lauren J. Maruca
    Cristi R. King
    Laura L. Jung
    Robert A. Parise
    Merrill J. Egorin
    Todd A. Davis
    Sharon Marsh
    Investigational New Drugs, 2006, 24 : 393 - 401
  • [24] Combined radiation and 9-nitrocamptothecin (Rubitecan) in the treatment of locally advanced pancreatic cancer
    Kemp, KR
    Liehr, JG
    Giovanella, B
    CAMPTOTHECINS: UNFOLDING THEIR ANTICANER POTENTIAL, 2000, 922 : 320 - 323
  • [25] Physicochemical Characterization, Solubilization, and Stabilization of 9-Nitrocamptothecin Using Pluronic Block Copolymers
    Saha, Sohodeb C.
    Patel, Deval
    Rahman, Shahidur
    Savva, Michalakis
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (10) : 3653 - 3665
  • [26] Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors
    Jung, LL
    Ramanathan, RK
    Egorin, MJ
    Jin, RZ
    Belani, CP
    Potter, DM
    Strychor, S
    Trump, DL
    Walko, C
    Fakih, M
    Zamboni, WC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 487 - 496
  • [27] Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice
    Knight, V
    Koshkina, NV
    Waldrep, JC
    Giovanella, BC
    Gilbert, BE
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (03) : 177 - 186
  • [28] Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats
    Chen, J
    Ping, QN
    Guo, JX
    Chu, XZ
    Song, MM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (02) : 53 - 59
  • [29] 9-nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats
    Dadashzadeh, Simin
    Derakhshandeh, Katayoun
    Shirazi, Farshad Hoseini
    ANTI-CANCER DRUGS, 2008, 19 (08) : 805 - 811
  • [30] Relationship between Lactone Ratios of 9-Nitrocamptothecin and their Lactone/Carboxylate Equilibria In Vitro and In Vivo
    Chen, Jun
    Hu, Rongrong
    Yang, Xixiong
    Tian, Rong
    Gu, Wei
    Chen, Zhipeng
    Cai, Baochang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (07): : 990 - 998
12345